DevicePMAs@therightstef:P890064_S021 / 234-237
|
Approval for a trade name change for the hybrid capture 2 (hc2) high-riskhpv dna test and hybrid capture 2 (hc2) hpv dna test. the devices, as modified, will bemarketed under the trade name digene hybrid capture 2 (hc2) high-risk hpv dna test anddigene hybrid capture 2 (hc2) hpv dna test and are indicated for the qualitative detectionof specified types of human papillomavirus (hpv) dna in cervical specimens.
|
projects
| Unselected / annnotation | Selected / annnotation | |
|
|
|
|